Tarsus Pharmaceuticals, Inc.
(TARS - NASDAQ)
60,93 USD
📋 Profilo Aziendale

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions.

|